Safety and efficacy of the Woven Endo-Bridge-17 device for intracranial aneurysm treatment: A systematic review and meta-analysis.

IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Interventional Neuroradiology Pub Date : 2024-01-17 DOI:10.1177/15910199231226294
Sherief Ghozy, Ahmed Sallam Motawei, Charbel Moussalem, Amro Elrefaei, Hassan Kobeissi, Alzhraa S Abbas, Adam A Dmytriw, David F Kallmes, Ramanathan Kadirvel
{"title":"Safety and efficacy of the Woven Endo-Bridge-17 device for intracranial aneurysm treatment: A systematic review and meta-analysis.","authors":"Sherief Ghozy, Ahmed Sallam Motawei, Charbel Moussalem, Amro Elrefaei, Hassan Kobeissi, Alzhraa S Abbas, Adam A Dmytriw, David F Kallmes, Ramanathan Kadirvel","doi":"10.1177/15910199231226294","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Woven Endo-Bridge (WEB) device revolutionized the treatment of wide-necked bifurcation aneurysms by intrasaccular flow diversion. The latest advancement is the WEB-17 system, offering greater flexibility with fewer wires, enabling treatment of smaller distal aneurysms using smaller microcatheters than the WEB-21 system.</p><p><strong>Methods: </strong>We conducted a systematic review following preferred reporting items for systematic reviews and meta-analyses guidelines, analyzing data from seven retrospective cohort studies involving 483 aneurysms treated with the WEB-17 device. Statistical analysis computed pooled prevalence rates and 95% confidence intervals using appropriate models for each outcome and R software version 4.3.1 (R Foundation for Statistical Computing, Vienna, Austria).</p><p><strong>Results: </strong>Technical success was achieved in 475 out of 483 aneurysms treated with the WEB-17 device, with a success rate of 98.34% (95% confidence interval (CI) = 96.72-99.17). Among the successful cases, 4.97% (95% CI = 1.60-14.39) required adjunctive devices. Adequate occlusion, defined as complete occlusion or neck remnants, was observed in 94.41% (95% CI = 88.17-97.46) of cases. Periprocedural complications were infrequent, with thromboembolic complications occurring in 4.93% (95% CI = 3.29-7.30) of cases, hemorrhagic complications in 1.28% (95% CI = 0.58-2.83), and postprocedural neurologic complications in 0.99% (95% CI = 0.31-3.14). Procedure-related morbidity was observed in 1.71% (95% CI = 0.86-3.39) of cases, and there was one procedure-related mortality reported at 0.21% (95% CI = .03-1.50). Mortality unrelated to the procedure occurred in 1% (95% CI = 0.23-4.15).</p><p><strong>Conclusion: </strong>Our findings suggest that the WEB-17 device is associated with a high rate of technical success, favorable angiographic outcomes, and a low rate of periprocedural complications. Further research, including prospective trials, is needed to confirm these findings and establish its safety and efficacy definitively.</p>","PeriodicalId":49174,"journal":{"name":"Interventional Neuroradiology","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Neuroradiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15910199231226294","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The Woven Endo-Bridge (WEB) device revolutionized the treatment of wide-necked bifurcation aneurysms by intrasaccular flow diversion. The latest advancement is the WEB-17 system, offering greater flexibility with fewer wires, enabling treatment of smaller distal aneurysms using smaller microcatheters than the WEB-21 system.

Methods: We conducted a systematic review following preferred reporting items for systematic reviews and meta-analyses guidelines, analyzing data from seven retrospective cohort studies involving 483 aneurysms treated with the WEB-17 device. Statistical analysis computed pooled prevalence rates and 95% confidence intervals using appropriate models for each outcome and R software version 4.3.1 (R Foundation for Statistical Computing, Vienna, Austria).

Results: Technical success was achieved in 475 out of 483 aneurysms treated with the WEB-17 device, with a success rate of 98.34% (95% confidence interval (CI) = 96.72-99.17). Among the successful cases, 4.97% (95% CI = 1.60-14.39) required adjunctive devices. Adequate occlusion, defined as complete occlusion or neck remnants, was observed in 94.41% (95% CI = 88.17-97.46) of cases. Periprocedural complications were infrequent, with thromboembolic complications occurring in 4.93% (95% CI = 3.29-7.30) of cases, hemorrhagic complications in 1.28% (95% CI = 0.58-2.83), and postprocedural neurologic complications in 0.99% (95% CI = 0.31-3.14). Procedure-related morbidity was observed in 1.71% (95% CI = 0.86-3.39) of cases, and there was one procedure-related mortality reported at 0.21% (95% CI = .03-1.50). Mortality unrelated to the procedure occurred in 1% (95% CI = 0.23-4.15).

Conclusion: Our findings suggest that the WEB-17 device is associated with a high rate of technical success, favorable angiographic outcomes, and a low rate of periprocedural complications. Further research, including prospective trials, is needed to confirm these findings and establish its safety and efficacy definitively.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于治疗颅内动脉瘤的 Woven Endo-Bridge-17 装置的安全性和有效性:系统回顾和荟萃分析。
背景:编织内桥(WEB)设备通过肌内血流分流彻底改变了宽颈分叉动脉瘤的治疗方法。与 WEB-21 系统相比,WEB-17 系统具有更大的灵活性和更少的导线,可以使用更小的微导管治疗更小的远端动脉瘤:我们按照系统综述和荟萃分析指南的首选报告项目进行了系统综述,分析了来自七项回顾性队列研究的数据,这些研究涉及使用 WEB-17 设备治疗的 483 个动脉瘤。统计分析针对每种结果使用适当的模型和 R 软件 4.3.1 版(奥地利维也纳 R 统计计算基金会)计算了汇总患病率和 95% 置信区间:在使用 WEB-17 设备治疗的 483 例动脉瘤中,有 475 例获得了技术成功,成功率为 98.34%(95% 置信区间 (CI) = 96.72-99.17)。在成功的病例中,4.97%(95% 置信区间 = 1.60-14.39)需要辅助装置。94.41%(95% CI = 88.17-97.46)的病例观察到充分闭塞,即完全闭塞或颈部残留。围手术期并发症并不常见,血栓栓塞并发症发生率为 4.93% (95% CI = 3.29-7.30),出血并发症发生率为 1.28% (95% CI = 0.58-2.83),术后神经系统并发症发生率为 0.99% (95% CI = 0.31-3.14)。1.71%(95% CI = 0.86-3.39)的病例出现了与手术相关的发病率,0.21%(95% CI = 0.03-1.50)的病例出现了与手术相关的死亡率。与手术无关的死亡率为 1%(95% CI = 0.23-4.15):我们的研究结果表明,WEB-17 装置的技术成功率高,血管造影结果良好,围手术期并发症发生率低。需要进一步的研究,包括前瞻性试验,来证实这些发现,并最终确定其安全性和有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Interventional Neuroradiology
Interventional Neuroradiology CLINICAL NEUROLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CiteScore
3.60
自引率
11.80%
发文量
192
审稿时长
6-12 weeks
期刊介绍: Interventional Neuroradiology (INR) is a peer-reviewed clinical practice journal documenting the current state of interventional neuroradiology worldwide. INR publishes original clinical observations, descriptions of new techniques or procedures, case reports, and articles on the ethical and social aspects of related health care. Original research published in INR is related to the practice of interventional neuroradiology...
期刊最新文献
Emergent endovascular treatment versus medical treatment for acute large vessel occlusions with nondisabling symptoms. Performance assessment of the Surpass Evolve flow diverter for the treatment of intracranial aneurysms: A systematic review and meta-analysis. Safety and efficacy of coated flow diverters in the treatment of cerebral aneurysms during single antiplatelet therapy: A multicenter study. Silk vista baby flow diversion beyond the circle of Willis: A single-center experience with long-term outcomes. WFITN 2024 - 17th Congress of World Federation of Interventional and Therapeutic Neuroradiology - October 6-10, 2024 - New York, USA.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1